Poultry Vaccines Market Size, Share Report by 2028

Poultry Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Broiler, Layer, and Breeder), Technology (Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, and Others), Dosage Form (Liquid Vaccines, Freeze-Dried Vaccines, and Dust/Powdered Vaccines), Disease [Newcastle Disease, Avian Influenza, Marek's Disease, Infectious Bronchitis (IB), Infectious Bursal Disease (IBD), Salmonellosis, and Others], Route of Administration [Drinking water (D/W) and Spray, Intramuscular (I/M), Subcutaneous (S/C), and Others], End User (Poultry Farms & Hatchery, Veterinary Hospitals, and Poultry Vaccination Centers & Clinics)

Publication Month : Apr 2022

  • Report Code : TIPRE00004772
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 241
Inquire Before Buy

PRICING

$4550

$3640

[Research Report] The poultry vaccines market is expected to grow from US$ 1,844.89 million in 2021 to US$ 2,845.00 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028.

The poultry industry in the US is the world's largest producer and second-largest exporter of poultry meat; it is also a major egg producer in the world. The country reports a high consumption of poultry meat (broilers, other chicken breeds, and turkey) than beef or pork. It exports ~18% of total poultry products and is heavily influenced by currency fluctuations, trade negotiations, and economic growth in importing markets.

According to the data published by the US department of agriculture (USDA), the country recorded a per capita poultry product consumption of 107.6 pounds in 2016, which increased to 113 pounds in 2021. This increase in production and consumption is one of the factors which is driving the poultry healthcare market. Technological advancements in vaccine manufacturing are also driving the global poultry vaccines market. For instance, in 2020, Boehringer Ingelheim’s Animal Health Business in the US launched the vaccine VAXXITEK HVT+IBD+ND that protects poultry from three diseases Marek’s Disease, infectious bursal disease (classic and variant types), and Newcastle disease. The business manufactures 60 billion doses of poultry vaccines in a year for use in the US and over 60 other countries, including Germany, Italy, China, and Japan. In 2020, Zoetis expanded its poultry vaccine product line with the introduction of Poulvac Procerta HVT-ND, a type of vectored recombinant vaccine that protects broiler chickens against Newcastle and Marek’s diseases. 

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Poultry Vaccines Market: Strategic Insights

poultry-vaccines-market
Market Size Value inUS$ 1,844.89 Million in 2021
Market Size Value byUS$ 2,845.00 Million by 2028
Growth rateCAGR of 6.4% from 2021 to 2028
Forecast Period2021-2028
Base Year2021
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Poultry vaccines are biological components (antigens) that provide active acquired immunity to specific poultry diseases. Another reason for poultry flock vaccination is hyper-immunizing hens to enhance the levels of maternally generated antibodies that are transferred through an egg to the hatching progeny.

Market Insights
Increasing Prevalence of Diseases in Poultry Boost Poultry Vaccine Market Growth

Poultry vaccine assists in averting a specific disease by accelerating the bird's immune system to generate antibodies to battle against the invading organisms. Poultry vaccines are essential for poultry disease control and the prevention of viral diseases. Vaccination helps prevent or reduce the adverse effects of specific conditions that can cause problems, such as infections in a poultry flock. Poultry vaccines are widely applied to avoid contagious poultry diseases and minimize the emergence of clinical disease at the farm level, thus increasing production. Zoonotic diseases, avian influenza viruses, and bird flu are the major poultry diseases.

For instance, in 24 EU/EEA countries and the UK, 1,672 highly pathogenic avian influenzas (HPAI) virus detections were recorded in poultry (n=580), wild (n=1,051), and captive birds (n=41) between February and May 2021. Poland detected 297 outbreaks in the region with dense poultry population during a short period, followed by Germany with 168 incidents. Most of the influenza outbreaks in poultry appeared to be linked to the cross-farm transmission and intra-community trafficking of live highly pathogenic avian influenza (HPAI) infected chickens. Germany led the way with 603 wild bird detections, followed by Denmark and Poland with 167 and 56, respectively. The second peak of HPAI-associated wild bird mortality was observed from February to April 2021 in Northwest Europe.

In the year 2020, the French Ministry of Agriculture confirmed the infection of highly pathogenic H5N8 avian influenza on 6,000 ducks from a duck farm in Benesse-Mariamne in Landes. The country already detected the H5N8 virus infection among birds sold in three pet stores in mid-November, 2020. Moreover, Saudi Arabia reported a highly pathogenic H5N8 avian influenza virus outbreak on a poultry farm. The emergence occurred in the Central Sudair region killed 22,700 birds. The other 385,300 birds in the flock were slaughtered. The case was the first outbreak of the H5N8 virus in Saudi Arabia since July 2018. Thus, the rising number of various poultry diseases is maximizing the demand for vaccines for chickens, thereby boosting the poultry vaccine market growth.

Disease–Based Insights

Based on disease, the global poultry vaccines market is segmented into infectious bronchitis, avian influenza, Marek’s disease, infectious bursal disease, Newcastle disease, salmonellosis, and others. The Newcastle disease segment held the largest share of the market in 2021, whereas the avian influenza segment is expected to register the highest CAGR during the forecast period.

Poultry Vaccines Market, by Disease – 2021–2028

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

The global poultry vaccines market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio globally as well as to meet the growing demand of poultry vaccines products. Inorganic growth strategies adopted by these players include partnerships and collaborations. These growth strategies help them in the expansion of their businesses and geographic presence. Additionally, growth strategies such as acquisitions and partnerships help in strengthening customer base and flourishing product portfolios. Organic strategies account for 60% of the total strategic developments in the global poultry vaccines market, whereas inorganic strategies account for 40% of these developments.

The global poultry vaccines market has been segmented as follows:

The global poultry vaccines market is segmented on the basis of type, technology, dosage form, route of administration, disease, and end user. Based on type, the market is segmented into broiler, layer, and breeder. The global poultry vaccines market, by technology, is segmented into live attenuated vaccines, inactivated vaccines, recombinant vaccines, and others. The market, based on dosage form, is divided into liquid vaccines, freeze-dried vaccines, and dust/powdered vaccines. The global poultry vaccines market, based on the route of administration, is divided into drinking water & spray, intramuscular, subcutaneous, and others. The market, by end user, is divided into poultry farms & hatcheries, veterinary hospitals, and poultry vaccination centers & clinics.

Company Profiles

  • Boehringer Ingelheim International GmbH
  • Zoetis Inc.
  • Ceva Santé Animale
  • BIOVAC
  • Phibro Animal Health CorporationHester Biosciences Limited
  • Venky's India
  • Dechra Pharmaceuticals PLC
  • Elanco
  • Merck Animal Health
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Type, Technology, Dosage Form, Disease, Route of Administration, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Poland, RoE, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What are poultry vaccines?

Poultry vaccines are biological components (antigens) that provide active or acquired or active immunity to specific diseases poultry. Vaccines are needed to develop active immunity to protect the poultry in a disease outbreak situation. Another reason for poultry flock vaccination is to hyper-immunize hens in order to increase the amount of maternally generated antibodies transferred through the egg to the hatching progeny.

What are the driving factors for the poultry vaccines market across the globe?

The factors that are driving the growth of the market are increasing prevalence of diseases in poultry and increasing demand for healthy poultry food.

Which disease will lead the poultry vaccines market?

The Newcastle disease segment is expected to be the leading disease segment in the poultry vaccines market in 2021.

Which type will hold the largest share in the poultry vaccines market?

The breeder segment is expected to be the leading type segment in the poultry vaccines market in 2021.

What is the regional market scenario of the poultry vaccines market?

The global poultry vaccines market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The largest market for poultry vaccines is held by the North American region. The United States held the largest market for poultry vaccines. The Asia-Pacific region is expected to be the fastest-growing region during the forecast period.

Who are the major players in the poultry vaccines market?

The poultry vaccines market majorly consists of the players such as Boehringer Ingelheim International GmbH; Zoetis Inc.; Ceva Santé Animale; BIOVAC; PHIBRO ANIMAL HEALTH CORPORATION; Hester Biosciences Limited; Venky's India; Dechra Pharmaceuticals PLC; Elanco; Merck Animal Health among others.

The List of Companies - Poultry Vaccine Market

  1. Boehringer Ingelheim International GmbH
  2. Zoetis Inc.
  3. Ceva Santé Animale
  4. BIOVAC
  5. Phibro Animal Health Corporation
  6. Hester Biosciences Limited
  7. Venky's India
  8. Dechra Pharmaceuticals PLC
  9. Elanco
  10. Merck Animal Health

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Poultry Vaccines Market